Forest Laboratories, Inc. (FRX) (JOBS) and Gedeon Richter Ltd. Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia
10/29/2009 6:37:56 AM
More...
|
Forest Laboratories, Inc. (FRX) and Gedeon Richter Ltd. Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia
10/28/2009 1:03:42 PM
More...
|
Phase Forward Inks Multi-Year Agreement with Major Eastern European Pharmaceutical Company Gedeon Richter Ltd.
10/1/2009 9:28:10 AM
More...
|
KV Pharmaceutical Company (KV-A) Forms Licensing Partnership with Gedeon Richter Ltd.
6/19/2009 7:32:25 AM
More...
|
DSM Biologics and Crucell N.V. (CRXL) Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter Ltd.
11/25/2008 10:33:58 AM
More...
|
DSM Biologics and Crucell N.V. (CRXL) Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter Ltd.
11/25/2008 8:15:24 AM
More...
|
Hungary's Gedeon Richter Ltd. to Build $103.7 Million Biotech Plant
7/22/2008 7:06:16 AM
More...
|
Gedeon Richter Ltd. Seeks $14.2 Million Compensation From Merck & Co., Inc. (MRK)
2/16/2006 10:52:40 AM
More...
|
Gedeon Richter Ltd. And Forest Laboratories, Inc. (FRX) Expand Relationship With Two New Collaborations For CNS Compounds
11/29/2005 10:59:08 AM
More...
|
Gedeon Richter Ltd. And Forest Laboratories, Inc. (FRX) Announce Collaboration Agreement On Atypical Antipsychotic For Schizophrenia, Bipolar Mania And Other Psychiatric Disorders
10/19/2005 5:12:17 PM
More...
|
|